• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COPD heterogeneity: implications for management.

作者信息

Barrecheguren Miriam, Miravitlles Marc

机构信息

Pneumology Department, Hospital Universitari Vall d'Hebron, P. Valld'Hebron 119-129, 08035 Barcelona, Spain.

出版信息

Multidiscip Respir Med. 2016 Mar 17;11:14. doi: 10.1186/s40248-016-0053-4. eCollection 2016.

DOI:10.1186/s40248-016-0053-4
PMID:26989488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4794904/
Abstract
摘要

相似文献

1
COPD heterogeneity: implications for management.
Multidiscip Respir Med. 2016 Mar 17;11:14. doi: 10.1186/s40248-016-0053-4. eCollection 2016.
2
Chronic care management for patients with COPD: a critical review of available evidence.慢性阻塞性肺疾病患者的慢性病管理：现有证据的批判性评价。
J Eval Clin Pract. 2013 Oct;19(5):734-52. doi: 10.1111/j.1365-2753.2011.01805.x. Epub 2011 Dec 2.
3
COPD heterogeneity: what this will mean in practice.COPD 异质性：这在实践中意味着什么。
Respir Care. 2011 Aug;56(8):1181-7. doi: 10.4187/respcare.01419.
4
Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management.慢性阻塞性肺疾病的异质性：健康风险评估、分层及管理面临的挑战
J Transl Med. 2014 Nov 28;12 Suppl 2(Suppl 2):S3. doi: 10.1186/1479-5876-12-S2-S3.
5
The 2014 ESPEN Arvid Wretlind Lecture: Metabolism & nutrition: Shifting paradigms in COPD management.2014 年 ESPEN 阿维德·雷特林德讲座：代谢与营养：COPD 管理中的范式转变。
Clin Nutr. 2015 Dec;34(6):1074-9. doi: 10.1016/j.clnu.2015.09.005. Epub 2015 Sep 26.
6
Oscillometry and pulmonary MRI measurements of ventilation heterogeneity in obstructive lung disease: relationship to quality of life and disease control.振荡法和肺部 MRI 测量在阻塞性肺疾病中的通气异质性：与生活质量和疾病控制的关系。
J Appl Physiol (1985). 2018 Jul 1;125(1):73-85. doi: 10.1152/japplphysiol.01031.2017. Epub 2018 Mar 15.
7
Health State Utility Value in Chronic Obstructive Pulmonary Disease (COPD); The Challenge of Heterogeneity: A Systematic Review and Meta-Analysis.慢性阻塞性肺疾病（COPD）中的健康状态效用值；异质性挑战：一项系统评价与Meta分析
COPD. 2016 Jun;13(3):380-98. doi: 10.3109/15412555.2015.1092953. Epub 2015 Dec 17.
8
Ventilation Heterogeneity in Never-smokers and COPD:: Comparison of Pulmonary Functional Magnetic Resonance Imaging with the Poorly Communicating Fraction Derived From Plethysmography.从不吸烟者和慢性阻塞性肺疾病患者的通气异质性：肺功能磁共振成像与体积描记法得出的通气不良分数的比较
Acad Radiol. 2016 Apr;23(4):398-405. doi: 10.1016/j.acra.2015.10.022. Epub 2016 Jan 8.
9
Complementary regional heterogeneity information from COPD patients obtained using oxygen-enhanced MRI and chest CT.利用氧增强 MRI 和胸部 CT 从 COPD 患者中获取补充的区域性异质性信息。
PLoS One. 2018 Aug 30;13(8):e0203273. doi: 10.1371/journal.pone.0203273. eCollection 2018.
10
Factor analysis in predominantly severe COPD: identification of disease heterogeneity by easily measurable characteristics.主要为重度 COPD 患者进行的因子分析：通过易于测量的特征来识别疾病异质性。
Respir Med. 2013 Dec;107(12):1939-47. doi: 10.1016/j.rmed.2013.07.011. Epub 2013 Aug 15.

引用本文的文献

1
Emerging Therapeutics in COPD: Mapping Innovation to Treatable Traits.慢性阻塞性肺疾病的新兴疗法：将创新与可治疗特征相对应
Lung. 2025 Sep 3;203(1):92. doi: 10.1007/s00408-025-00844-0.
2
An analysis of the regional heterogeneity in tissue elasticity in lung cancer patients with COPD.慢性阻塞性肺疾病（COPD）合并肺癌患者组织弹性区域异质性分析
Front Med (Lausanne). 2023 Sep 28;10:1151867. doi: 10.3389/fmed.2023.1151867. eCollection 2023.
3
Telehealth nursing interventions for phenotypes of older adults with COPD: an exploratory study.慢性阻塞性肺疾病老年患者表型的远程医疗护理干预：一项探索性研究。
Front Digit Health. 2023 Sep 21;5:1144075. doi: 10.3389/fdgth.2023.1144075. eCollection 2023.
4
Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?可治疗的特征可否作为解决 COPD 复杂性和异质性的方法？
Int J Chron Obstruct Pulmon Dis. 2023 Sep 8;18:1959-1964. doi: 10.2147/COPD.S428391. eCollection 2023.
5
Analysis of the Comorbid Course of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病共病病程分析
J Pers Med. 2023 Jul 24;13(7):1179. doi: 10.3390/jpm13071179.
6
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score.比较慢性阻塞性肺疾病三联固定剂量组合的疗效和安全性：一项荟萃分析和IBiS评分
J Clin Med. 2022 Aug 1;11(15):4491. doi: 10.3390/jcm11154491.
7
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective.《关于慢性阻塞性肺疾病诊断和管理的卫生系统政策变更的质量标准立场声明：全球视角》。
Adv Ther. 2022 Jun;39(6):2302-2322. doi: 10.1007/s12325-022-02137-x. Epub 2022 Apr 28.
8
Extracting Disease-Relevant Features with Adversarial Regularization.利用对抗正则化提取疾病相关特征
Proceedings (IEEE Int Conf Bioinformatics Biomed). 2021 Dec;2021:3464-3471. doi: 10.1109/bibm52615.2021.9669878.
9
Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases.利用细胞外基质微环境改善慢性肺病中基于间充质基质细胞的治疗
Front Pharmacol. 2021 Apr 15;12:645558. doi: 10.3389/fphar.2021.645558. eCollection 2021.
10
Chronic hypoxaemia and gender status modulate adiponectin plasmatic level and its multimer proportion in severe COPD patients: new endotypic presentation?慢性低氧血症和性别状态调节严重 COPD 患者脂联素的血浆水平及其多聚体比例：新的表型表现？
BMC Pulm Med. 2020 Oct 1;20(1):255. doi: 10.1186/s12890-020-01288-3.

本文引用的文献

1
A review of national guidelines for management of COPD in Europe.欧洲慢性阻塞性肺疾病管理国家指南综述。
Eur Respir J. 2016 Feb;47(2):625-37. doi: 10.1183/13993003.01170-2015. Epub 2016 Jan 21.
2
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD.血液嗜酸性粒细胞与慢性阻塞性肺疾病中吸入性糖皮质激素/长效β-2受体激动剂的疗效
Thorax. 2016 Feb;71(2):118-25. doi: 10.1136/thoraxjnl-2015-207021. Epub 2015 Nov 19.
3
Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?对于慢性阻塞性肺疾病（COPD）患者，既往哮喘诊断是否是哮喘-慢性阻塞性肺疾病重叠综合征的可靠标准？
Int J Chron Obstruct Pulmon Dis. 2015 Sep 1;10:1745-52. doi: 10.2147/COPD.S87025. eCollection 2015.
4
Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD.慢性阻塞性肺疾病中肺过度充气的机制、评估及治疗意义
Respir Med. 2015 Jul;109(7):785-802. doi: 10.1016/j.rmed.2015.03.010. Epub 2015 Apr 3.
5
A new algorithm for the management of COPD.一种用于慢性阻塞性肺疾病管理的新算法。
Lancet Respir Med. 2015 Apr;3(4):266-8. doi: 10.1016/S2213-2600(15)00091-0.
6
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.血液嗜酸性粒细胞计数、加重情况以及慢性阻塞性肺疾病患者添加吸入氟替卡松维兰特罗后的反应：两项平行随机对照试验数据的二次分析。
Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12.
7
The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.哮喘-慢性阻塞性肺疾病重叠综合征（ACOS）：机遇与挑战
Curr Opin Pulm Med. 2015 Jan;21(1):74-9. doi: 10.1097/MCP.0000000000000118.
8
Spanish guideline for COPD (GesEPOC). Update 2014.西班牙慢性阻塞性肺疾病指南（GesEPOC）。2014年更新版。
Arch Bronconeumol. 2014 Jan;50 Suppl 1:1-16. doi: 10.1016/S0300-2896(14)70070-5.
9
Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care.慢性阻塞性肺疾病：捷克肺病与结核病学会官方诊断与治疗指南；一种以患者为导向的慢性阻塞性肺疾病新型表型治疗方法
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Jun;157(2):189-201. doi: 10.5507/bp.2013.039. Epub 2013 May 24.
10
Clinical phenotypes of COPD: identification, definition and implications for guidelines.COPD 的临床表型：识别、定义及对指南的影响。
Arch Bronconeumol. 2012 Mar;48(3):86-98. doi: 10.1016/j.arbres.2011.10.007. Epub 2011 Dec 22.